Effect of clarithromycin on airway obstruction and inflammatory markers in induced sputum in cystic fibrosis:: A pilot study

被引:65
|
作者
Ordoñez, CL
Stulbarg, M
Grundland, H
Liu, JT
Boushey, HA
机构
[1] Childrens Hosp, Dept Med, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Med Allergy & Immunol, San Francisco, CA 94143 USA
关键词
cystic fibrosis; inflammation; sputum induction; inflammatory marker; macrolides;
D O I
10.1002/ppul.1085
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
To determine whether macrolide antibiotics improve pulmonary function and decrease airway inflammation in cystic fibrosis (CF), we treated 10 patients (4 females; aged 19-26 years, all colonized with P. aeruginosa, none with atypical Mycobacteria) with 3 weeks of placebo, followed by 6 weeks of clarithromycin (500 mg BID) in a single-blind prospective study. We also determined the safety of sputum induction and the reproducibility of assessing inflammatory markers in induced sputum. Subjects performed spirometry and underwent sputum induction (12-min inhalation of 3% saline) at 3-week intervals. We found that sputum induction was well-tolerated. We also found that the reproducibility was high for neutrophil (PMN) number (R = 0.87, P = 0.009), interleukin (IL)-8 (R = 0.73, P < 0.05), free neutrophil elastase (NE) (R = 0.82, P < 0.05), and myeloperoxidase (MPO) levels (R = 0.86, P < 0.05), but was less so for tumor necrosis factor (TNF)-alpha (R = -0.15, P = 0.7). We found no significant difference in pulmonary function after 6 weeks of treatment with clarithromycin (FEV, (% predicted) (mean +/- SEM), 2.2 +/- 0.9 (60 +/- 24%) vs. 2.3 +/- 1 (61 +/- 29%)), and no significant differences in any of the inflammatory indices measured. The median land range) values before and after treatment for indices of airway inflammation in the induced sputum samples were: for PMNs, 8 (1-326) and 21 (0.2 -175) x 10(6) cells/mL sputum; for IL-8, 156 (24-656) and 202 (16-680) ng/mL; for free NE, 260 (31-1,264) and 237 (49-1,048) mug/mL; for TNF-alpha(, 20 (7-128) and 35 (17-87) pg/mL; and for MPO, 169 (13-960) and 195 (14-816) mug/mL. We conclude that clarithromycin is not uniformly effective in improving airway obstruction or in decreasing airway inflammation in patients with CF. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:29 / 37
页数:9
相关论文
共 50 条
  • [21] Use of the Lung Flute for Sputum Induction in Children With Cystic Fibrosis: A Pilot Study
    Doumit, Michael
    Jaffe, Adam
    PEDIATRIC PULMONOLOGY, 2015, 50 (04) : 340 - 343
  • [22] Pro-inflammatory effect of cystic fibrosis sputum microparticles in the murine lung
    Porro, Chiara
    Di Gioia, Sante
    Trotta, Teresa
    Lepore, Silvia
    Panaro, Maria Antonietta
    Battaglino, Anna
    Ratclif, Luigi
    Castellani, Stefano
    Bufo, Pantaleo
    Martinez, Maria Carmen
    Conese, Massimo
    JOURNAL OF CYSTIC FIBROSIS, 2013, 12 (06) : 721 - 728
  • [23] INFLAMMATORY MARKERS IN CYSTIC-FIBROSIS
    RAYNER, RJ
    WISEMAN, MS
    CORDON, SM
    NORMAN, D
    HILLER, EJ
    SHALE, DJ
    RESPIRATORY MEDICINE, 1991, 85 (02) : 139 - 145
  • [25] Mechanisms and markers of airway inflammation in cystic fibrosis
    De Rse, V
    EUROPEAN RESPIRATORY JOURNAL, 2002, 19 (02) : 333 - 340
  • [26] METABOLOMICS OF INDUCED SPUTUM IN EARLY CYSTIC FIBROSIS
    Moncada, D. M.
    Giacalone, V. D.
    Kilgore, M. B.
    Brown, M.
    Silva, G. L.
    Esther, C. R., Jr.
    Tirouvanziam, R.
    Guglani, L.
    Chandler, J. D.
    PEDIATRIC PULMONOLOGY, 2020, 55 : S52 - S53
  • [27] Cystic fibrosis presenting as acute upper airway obstruction
    Davies, J
    Chaudry, R
    LaRovere, J
    Hansell, D
    Dawson, M
    Abrahamson, E
    THORAX, 2006, 61 (01) : 92 - 92
  • [28] REVERSIBLE AIRWAY-OBSTRUCTION IN CYSTIC-FIBROSIS
    ORMEROD, LP
    THOMSON, RA
    ANDERSON, CM
    STABLEFORTH, DE
    THORAX, 1980, 35 (10) : 768 - 772
  • [29] Sputum Inflammation Markers as Predictors of Acute Exacerbations in Cystic Fibrosis
    Zielonka, J.
    Khanal, S.
    Niu, N.
    Slade, M. S.
    Chupp, G. L.
    Britto-Leon, C. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [30] INDUCED SPUTUM AS AN ALTERNATIVE TO BRONCHOALVEOLAR LAVAGE FOR EVALUATION OF AIRWAY INFLAMMATION IN YOUNG CHILDREN WITH CYSTIC FIBROSIS
    Giacalone, V. D.
    Margaroli, C.
    Dobosh, B.
    Brown, M.
    Silva, G. L.
    Peng, L.
    Chandler, J. D.
    Tirouvanziam, R.
    Guglani, L.
    PEDIATRIC PULMONOLOGY, 2019, 54 : S157 - S158